These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34393517)
1. Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing. Balendran-Braun S; Kieler M; Liebmann-Reindl S; Unseld M; Bianconi D; W Prager G; Streubel B Cancer Manag Res; 2021; 13():6249-6261. PubMed ID: 34393517 [TBL] [Abstract][Full Text] [Related]
4. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study. Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950 [TBL] [Abstract][Full Text] [Related]
5. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program. Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761 [TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer. Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585 [TBL] [Abstract][Full Text] [Related]
7. Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study. Lee JS; Han Y; Yun WG; Kwon W; Kim H; Jeong H; Seo MS; Park Y; Cho SI; Kim H; Kim JY; Seong MW; Jang JY; Park SS Clin Chem; 2022 Dec; 68(12):1509-1518. PubMed ID: 36177751 [TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer. Shah D; Wells A; Cox M; Dawravoo K; Abad J; D'Souza A; Suh G; Bayer R; Chaudhry S; Zhang Q; Cristofanilli M; Bentrem D; Chawla A Ann Surg; 2024 Jan; ():. PubMed ID: 38258582 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer. Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854 [TBL] [Abstract][Full Text] [Related]
10. The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer. Cai J; Jiang H; Li S; Yan X; Wang M; Li N; Zhu C; Dong H; Wang D; Xu Y; Xie H; Wu S; Lou J; Zhao J; Li Q Front Oncol; 2021; 11():751106. PubMed ID: 35273907 [TBL] [Abstract][Full Text] [Related]
11. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661 [TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Alqahtani A; Alloghbi A; Coffin P; Yin C; Mukherji R; Weinberg BA Surg Oncol; 2023 Dec; 51():102007. PubMed ID: 37852124 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Guan S; Deng G; Sun J; Han Q; Lv Y; Xue T; Ding L; Yang T; Qian N; Dai G Front Oncol; 2022; 12():926260. PubMed ID: 36081557 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer. Watanabe F; Suzuki K; Tamaki S; Abe I; Endo Y; Takayama Y; Ishikawa H; Kakizawa N; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T PLoS One; 2019; 14(12):e0227366. PubMed ID: 31891652 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer. Lee B; Lipton L; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Burge M; Cooray P; Nagrial A; Tebbutt NC; Thomson B; Nikfarjam M; Harris M; Haydon A; Lawrence B; Tai DWM; Simons K; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P Ann Oncol; 2019 Sep; 30(9):1472-1478. PubMed ID: 31250894 [TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients. Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065 [TBL] [Abstract][Full Text] [Related]
17. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results. Hicks JK; Saller J; Wang E; Boyle T; Gray JE Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384 [TBL] [Abstract][Full Text] [Related]
18. Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer. Berger AW; Schwerdel D; Ettrich TJ; Hann A; Schmidt SA; Kleger A; Marienfeld R; Seufferlein T Oncotarget; 2018 Jan; 9(2):2076-2085. PubMed ID: 29416754 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy. Zhang M; Qi C; Wang Z; Chen H; Zhao X; Zhang X; Zhou Y; Gao C; Bai Y; Jia S; Ji J J Mol Med (Berl); 2021 Sep; 99(9):1311-1321. PubMed ID: 34057552 [TBL] [Abstract][Full Text] [Related]
20. Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer. Adamo P; Cowley CM; Neal CP; Mistry V; Page K; Dennison AR; Isherwood J; Hastings R; Luo J; Moore DA; Howard PJ; Miguel ML; Pritchard C; Manson M; Shaw JA Oncotarget; 2017 Oct; 8(50):87221-87233. PubMed ID: 29152076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]